KR102199092B1 - 지혈 폼 - Google Patents

지혈 폼 Download PDF

Info

Publication number
KR102199092B1
KR102199092B1 KR1020157017745A KR20157017745A KR102199092B1 KR 102199092 B1 KR102199092 B1 KR 102199092B1 KR 1020157017745 A KR1020157017745 A KR 1020157017745A KR 20157017745 A KR20157017745 A KR 20157017745A KR 102199092 B1 KR102199092 B1 KR 102199092B1
Authority
KR
South Korea
Prior art keywords
foam
liquid foam
pharmaceutical
albumin
hemostatic liquid
Prior art date
Application number
KR1020157017745A
Other languages
English (en)
Korean (ko)
Other versions
KR20150093198A (ko
Inventor
안드레아스 게슬
카타르지나 고르나
Original Assignee
백스터 인터내셔널 인코포레이티드
박스터 헬쓰케어 에스에이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 백스터 인터내셔널 인코포레이티드, 박스터 헬쓰케어 에스에이 filed Critical 백스터 인터내셔널 인코포레이티드
Publication of KR20150093198A publication Critical patent/KR20150093198A/ko
Application granted granted Critical
Publication of KR102199092B1 publication Critical patent/KR102199092B1/ko

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0052—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0085—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00—Devices for applying media, e.g. remedies, on the human body
    • A61M35/003—Portable hand-held applicators having means for dispensing or spreading integral media
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
KR1020157017745A 2012-12-07 2013-12-06 지혈 폼 KR102199092B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261734544P 2012-12-07 2012-12-07
US61/734,544 2012-12-07
PCT/EP2013/075852 WO2014086996A1 (en) 2012-12-07 2013-12-06 Hemostatic foam

Publications (2)

Publication Number Publication Date
KR20150093198A KR20150093198A (ko) 2015-08-17
KR102199092B1 true KR102199092B1 (ko) 2021-01-07

Family

ID=49725129

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020157017745A KR102199092B1 (ko) 2012-12-07 2013-12-06 지혈 폼

Country Status (15)

Country Link
US (2) US10307509B2 (ja)
EP (1) EP2928511B1 (ja)
JP (1) JP2016501255A (ja)
KR (1) KR102199092B1 (ja)
CN (1) CN104902935B (ja)
AU (1) AU2013353931B2 (ja)
BR (1) BR112015012985B8 (ja)
CA (1) CA2893064C (ja)
ES (1) ES2804534T3 (ja)
HK (1) HK1212928A1 (ja)
IL (1) IL238948A0 (ja)
MX (1) MX356867B (ja)
SG (1) SG11201504347RA (ja)
WO (1) WO2014086996A1 (ja)
ZA (1) ZA201503973B (ja)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102014973A (zh) 2008-02-29 2011-04-13 弗罗桑医疗设备公司 用于促进止血和/或伤口愈合的装置
CN104010669A (zh) * 2011-10-28 2014-08-27 巴克斯特国际公司 用于骨骼止血的非水性组合物以及它们的使用和制造方法
CA2865349C (en) 2012-03-06 2021-07-06 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
RU2636240C2 (ru) 2012-06-12 2017-11-21 Ферросан Медикал Дивайсиз А/С Сухая гемостатическая композиция
WO2014086996A1 (en) * 2012-12-07 2014-06-12 Baxter International Inc. Hemostatic foam
US10201690B2 (en) * 2013-06-19 2019-02-12 Robert Nutter Wound injector apparatus
AU2014283170B2 (en) 2013-06-21 2017-11-02 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
RU2678592C1 (ru) 2013-12-11 2019-01-30 Ферросан Медикал Дивайсиз А/С Сухая композиция, содержащая компонент, улучшающий экструзию
WO2016058612A1 (en) 2014-10-13 2016-04-21 Ferrosan Medical Devices A/S Dry composition for use in haemostasis and wound healing
AU2015371184B2 (en) 2014-12-24 2020-06-25 Ferrosan Medical Devices A/S Syringe for retaining and mixing first and second substances
US10283015B2 (en) 2015-04-08 2019-05-07 Biom'up Device and method for simulation of surface bleedings
EP3316930B1 (en) 2015-07-03 2019-07-31 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
MA46239A (fr) 2016-09-14 2019-07-24 Ethicon Inc Mousse pharmaceutique stable
IL247810A0 (en) 2016-09-14 2017-01-31 Omrix Biopharmaceuticals Ltd Stable pharmaceutical foam
US10980913B2 (en) 2018-03-05 2021-04-20 Ethicon Llc Sealant foam compositions for lung applications
BR112020021998A2 (pt) 2018-05-09 2021-01-26 Ferrosan Medical Devices A/S métodos para preparar uma composição hemostática e para reconstituir uma composição de trombina seca, composição hemostática, e, estojo.
DE102018009781A1 (de) 2018-12-13 2020-06-18 Valeopharm GmbH Verschäumbare wässrige Zubereitungen auf natürlicher Biopolymerbasis mit einsatzflexibler Gas(- vor allem Sauerstoffgas)-Speicherzellen-Verteilung
WO2021014356A1 (en) * 2019-07-23 2021-01-28 Kci Licensing, Inc. Foam compositions for wound treatment, systems of delivery, and methods of use
US11903961B2 (en) 2020-08-18 2024-02-20 Amrita Vishwa Vidyapeetham Hemostatic agent and method of production thereof
US20220241521A1 (en) * 2021-02-02 2022-08-04 Freedom Corp. Device for fibrin-biopolymer-forming substance application
WO2023170680A1 (en) 2022-03-08 2023-09-14 Equashield Medical Ltd Fluid transfer station in a robotic pharmaceutical preparation system
WO2023177392A1 (en) * 2022-03-15 2023-09-21 Mayo Foundation For Medical Education And Research Tissue displacement foam

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011151384A1 (en) 2010-06-01 2011-12-08 Baxter International Inc. Process for making dry and stable hemostatic compositions

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6054122B2 (ja) * 1977-12-12 1985-11-28 日新製鋼株式会社 準安定オ−ステナイト系ステンレス鋼の冷間圧延方法
ATE13810T1 (de) * 1981-06-25 1985-07-15 Serapharm Gmbh & Co Kg Angereichertes plasmaderivat zur unterstuetzung von wundverschluss und wundabdeckung.
JP2796558B2 (ja) 1986-04-01 1998-09-10 セイコーインスツルメンツ株式会社 液晶電気光学素子
US4892826A (en) * 1988-10-11 1990-01-09 Abbott Laboratories Process for the preparation of urokinase derivatives
US6054122A (en) 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
FR2796558B1 (fr) * 1999-07-21 2001-10-19 Imedex Biomateriaux Mousse adhesive a usage chirurgical et/ou therapeutique, et procede et kit pour son obtention
WO2001005443A1 (fr) * 1999-07-21 2001-01-25 Imedex Biomateriaux Mousse proteique adhesive a usage chirurgical et/ou therapeutique
EP1257304B1 (en) 2000-02-25 2004-02-04 David Sierra Foam-forming wound dressing
AR032517A1 (es) * 2001-01-25 2003-11-12 Nycomed Pharma As Un metodo para preparar una esponja de colageno, un dispositivo para extraer una parte de una espuma de colageno, y una esponja de colageno alargada
US20030211137A1 (en) * 2001-02-21 2003-11-13 David Sierra Foam-forming wound dressing
US6703299B2 (en) 2001-12-21 2004-03-09 Intel Corporation Underfill process for flip-chip device
DK1973475T3 (da) 2006-01-17 2010-10-18 Baxter Int Blandeindretning, -system og -fremgangsmåde
BRPI0708429A2 (pt) * 2006-03-01 2011-05-31 Fmc Biopolymer As método para formar uma espuma absorvente seca, espuma absorvente seca, compósito, uso de uma espuma ou de um compósito, e, métodos para inibir a proliferação celular, para fixar um compósito ao tecido e para evitar a adesão de tecido a tecido adjacente
GB0623607D0 (en) * 2006-11-27 2007-01-03 Haemostatix Ltd Tissue adhesive
US8753670B2 (en) 2008-03-26 2014-06-17 Baxter International Inc. Fibrin foam and process
US8512740B2 (en) 2008-03-26 2013-08-20 Baxter International Inc. Fibrin foam and process for making
US9629798B2 (en) * 2008-04-03 2017-04-25 Mallinckrodt Pharma Ip Trading D.A.C. Hemostatic microspheres
WO2011083154A1 (en) * 2010-01-08 2011-07-14 Profibrix Bv Dry powder fibrin sealant
WO2014086996A1 (en) * 2012-12-07 2014-06-12 Baxter International Inc. Hemostatic foam

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011151384A1 (en) 2010-06-01 2011-12-08 Baxter International Inc. Process for making dry and stable hemostatic compositions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
미국등록특허공보 제6054122호 (2000.04.25.자) 1부.*

Also Published As

Publication number Publication date
ZA201503973B (en) 2016-04-28
CA2893064C (en) 2021-05-04
BR112015012985B8 (pt) 2020-04-14
EP2928511A1 (en) 2015-10-14
KR20150093198A (ko) 2015-08-17
HK1212928A1 (zh) 2016-06-24
IL238948A0 (en) 2015-07-30
JP2016501255A (ja) 2016-01-18
US20140161738A1 (en) 2014-06-12
US9168325B2 (en) 2015-10-27
CA2893064A1 (en) 2014-06-12
AU2013353931A1 (en) 2015-06-11
CN104902935B (zh) 2017-11-24
SG11201504347RA (en) 2015-07-30
CN104902935A (zh) 2015-09-09
ES2804534T3 (es) 2021-02-08
US10307509B2 (en) 2019-06-04
WO2014086996A1 (en) 2014-06-12
AU2013353931B2 (en) 2016-12-08
US20150314037A1 (en) 2015-11-05
MX2015007194A (es) 2016-03-07
EP2928511B1 (en) 2020-04-22
MX356867B (es) 2018-06-18
BR112015012985B1 (pt) 2020-03-17

Similar Documents

Publication Publication Date Title
KR102199092B1 (ko) 지혈 폼
AU2011204558B2 (en) Dry powder fibrin sealant
JP4535678B2 (ja) フィブリノーゲン、トロンビン、およびアルコールを含む懸濁液、該懸濁液を調製する方法、該懸濁液によって担体をコーティングする方法、担体のコーティングを乾燥させる方法、およびコーティングされたコラーゲンスポンジ
EP2726115B1 (en) Procoagulant peptides and their derivatives and uses therefor
RU2715235C2 (ru) Сухая композиция для использования при гемостазе и заживлении ран
WO2019171215A1 (en) Sealant foam compositions for lung applications
JP5820807B2 (ja) フィブリンシーラント
Kheirabadi et al. High-pressure fibrin sealant foam: an effective hemostatic agent for treating severe parenchymal hemorrhage
EP3122260A1 (en) Device and method for preparing and administering one-component fibrin sealant
US9289196B2 (en) Hemostatic substance with a coating
BR112012018970B1 (pt) produto compreendendo fibrinogênio, thrombina e formulação de selante de fibrina líquida, método para preparação do mesmo e kit
ES2741015T3 (es) Almohadilla seca que comprende trombina y pectina
WO2005072623A1 (en) Haemostatic device

Legal Events

Date Code Title Description
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant